NO
Metabolism of small antimicrobial ß2,2-amino acid derivatives by murine liver microsomes.
Hansen, T.; Moe, M.K.; Anderssen, T.; Strøm, M.B.
2012
Scientific journal publication
The structure of the fire fighting foam surfactant Forafac®1157 and its biological and photolytic transformation products.
Moe, M.K.; Huber, S.; Svenson, J.; Hagenaars, A.; Pabon, M.; Trümper, M.; Berger, U.; Knapen, D.; Herzke, D.
Plasma concentrations of parabens in postmenopausal women and self-reported use of personal care products: the NOWAC postgenome study.
Sandanger, T.M.; Huber, S.; Moe, M.K.; Braathen, T.; Leknes, H.; Lund, E.
2011
Perfluorinated compounds in maternal serum and cord blood from selected areas of South Africa: results of a pilot study.
Hanssen, L.; Röllin, H.; Odland, J.Ø.; Moe, M.K.; Sandanger, T.M.
2010
Retrospective environmental risk assessment of human pharmaceuticals in the Nordic countries 1997-2007.
Woldegiorgis, A.; Wiklund, P.; Moe, M.
2009
Report
Emissions from incineration of fluoropolymer materials. A literature survey.
Huber, S.; Moe, M.K.; Schmidbauer, N.; Hansen, G.H.; Herzke, D.
Environmental screening of selected organic compounds 2008. Human and hospital-use pharmaceuticals, aquaculture medicines and personal care products.
Schlabach, M.; Dye, C.; Kaj, L.; Klausen, S.; Langford, K.; Leknes, H.; Moe, M.K.; Remberger, M.; Schøyen, M.; Thomas, K.; Vogelsang, C.
Environmental impact of amines from CO2 capture.
Knudsen, S.; Moe, M.K.; Schlabach, M.; Schmidbauer, N.; Dye, C.
2008
Pharmaceutical residues in Northern European environment: consequences and perspectives.
Kallenborn, R.; Fick, J.; Lindberg, R.; Moe, M.; Nielsen, K.M.; Tysklind, M.; Vasskog, T.
Part of book/report
Human and veterinary pharmaceuticals, narcotics and personal care products in the environment. Current state of knowledge and monitoring requirements.
Grung, M.; Heimstad, E.S.; Moe, M.; Schlabach, M.; Svenson, A. Thomas, K.; Woldegiorgis, A.
